Tebao Bio (688278)
SSE · 688278
Market Cap$22.1B
Revenue$3.8B
Employees3644
Listed OnSSE
Ticker688278
CEO / ExecMr. Li Sun
HeadquartersXiamen
MarketMainland China
Websitewww.amoytop.com
Overview
Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally. It offers various drug products, including pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin; active pharmaceutical ingredients (APIs); and reagents to treat viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is headquartered in Xiamen, China.
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.